EGCG showed promising results on prostate cancer stem cells through the inhibition of colony and spheres formation, the inhibition of EMT, the down-regulation of vimentin, Bcl-2, and survivin, and the up-regulation of caspase-3 and apoptosis induction [152]. This evidence concerns the gene BCL2 and prostate carcinoma.